Literature DB >> 11222806

Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD.

J Volkmann1, N Allert, J Voges, P H Weiss, H J Freund, V Sturm.   

Abstract

The authors retrospectively compared 1-year results of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN; n = 16) and internal pallidum (GPi) (n = 11) in advanced PD and found about equal improvements in "off" period motor symptoms, dyskinesias, and fluctuations. STN stimulation reduced medication requirements by 65% and required significantly less electrical power. These advantages contrasted with a need for more intensive postoperative monitoring and a higher incidence of adverse events related to levodopa withdrawal.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222806     DOI: 10.1212/wnl.56.4.548

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  73 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Surgery for movement disorders.

Authors:  Ralph Gregory
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

3.  MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Authors:  N K Patel; P Plaha; K O'Sullivan; R McCarter; P Heywood; S S Gill
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

4.  Chronic high-frequency stimulation therapy in hemiparkinsonian rhesus monkeys using an implanted human DBS system.

Authors:  Yiqun Cao; Peihao Yin; Xiaowu Hu; Yiqin Ge; Xiaoping Zhou
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

5.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

6.  Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany.

Authors:  Wassilios Meissner; Doreen Schreiter; Jens Volkmann; Thomas Trottenberg; Gerd-Helge Schneider; Volker Sturm; Guenther Deuschl; Andreas Kupsch
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

7.  Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease.

Authors:  K Kalteis; H Standhardt; I Kryspin-Exner; T Brücke; D Volc; F Alesch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

Review 8.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

9.  Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease.

Authors:  T J Loher; J-M Burgunder; S Weber; R Sommerhalder; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

10.  Subthalamic Nucleus Deep Brain Stimulation Modulates 2 Distinct Neurocircuits.

Authors:  Lunhao Shen; Changqing Jiang; Catherine S Hubbard; Jianxun Ren; Changgeng He; Danhong Wang; Louisa Dahmani; Yi Guo; Yiming Liu; Shujun Xu; Fangang Meng; Jianguo Zhang; Hesheng Liu; Luming Li
Journal:  Ann Neurol       Date:  2020-10-13       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.